Fennec Pharmaceuticals

Three new postings were observed during the window. The Southeast Key Account Director role is responsible for strategic engagement with major oncology accounts and for building and pulling through PEDMARK plans at large community oncology practices and academic institutions. The Vice President role would lead global pharmacovigilance, medical safety, and regulatory activities, including safety surveillance, regulatory strategy, health-authority engagement, submissions, and commitments. The HR-­

A Key Account Director posting was observed on September 30, 2026 for the Southeast, covering Florida, Puerto Rico, Georgia, and the Carolinas. The role is tasked with engaging C-suite and senior stakeholders at large community oncology practices, academic institutions, and GPO accounts, while coordinating with market access, marketing, product strategy, sales, and medical affairs to reduce access barriers and support PEDMARK clinical utilization. This is an observed commercial hiring need, not 

Provider-observed headcount was 58 on September 8, 2026 and 58 on October 8, 2026, a change of zero over the stated rolling 30-day window. The latest observation was successful and complete. Separately, no inferred departures were first observed during the window among 40 tracked employees, 35 of whom had a successful observation in the prior seven days; this tracked-person result is not a companywide departure census.